Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Standard Postoperative Analgesics (E-DA Hospital) is a multimodal analgesic regimen utilized for the management of postoperative pain, specifically evaluated in patients undergoing Ferguson haemorrhoidectomy. The regimen consists of a combination of three pharmaceutical agents: acetaminophen (paracetamol), an oral non-opioid analgesic and antipyretic; celecoxib, an oral selective cyclooxygenase-2 (COX-2) inhibitor; and parecoxib (marketed as Dynastat), an intravenous prodrug of valdecoxib that also selectively inhibits COX-2. This combination is designed to provide synergistic pain relief by targeting prostaglandin synthesis through multiple pathways and administration routes, aiming to optimize pain control while minimizing the requirement for rescue analgesia or opioids in the immediate postoperative period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + celecoxib + parecoxib.